Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03074513
Title Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

vulva squamous cell carcinoma

appendix adenocarcinoma

penis squamous cell carcinoma

nasopharynx carcinoma

malignant pleural mesothelioma

pancreatic endocrine carcinoma

vaginal squamous tumor

cervical cancer

neuroendocrine tumor

anal canal squamous cell carcinoma

neuroendocrine carcinoma

Merkel cell carcinoma

peritoneal mesothelioma

Therapies

Atezolizumab + Bevacizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.